Dalfampridine Tablet, Extended Release Shortage
Last Updated: September 20, 2024
Status: Discontinued
To Be Discontinued:
Tablet, Extended Release, 10 mg (Sun Pharmaceutical Industries, Inc.)
NDC Code: 62756-429-86Status: To Be Discontinued
Date of update: September 20, 2024
Update type: New
Therapeutic category: Neurology
Date discontinued: September 20, 2024
Initial posting date: September 20, 2024
Contact info: 800-818-4555
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.